The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1011917 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Senko Tsukuda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Medicine, University of Oxford, United Kingdom. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B virus. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIAID NIH HHS, Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Chronic hepatitis B is a global health problem and current treatments only suppress hepatitis B virus (HBV) infection, highlighting the need for new curative treatments. Oxygen levels influence HBV replication and we previously reported that hypoxia inducible factors (HIFs) activate the basal core promoter (BCP). Here we show that the hypoxic-dependent increase in BCP-derived transcripts is dependent on N 6 -methyladenosine (m 6 A) modifications in the 5’ stem loop that regulate RNA half-life. Application of a probe-enriched long-read sequencing method to accurately map the HBV transcriptome showed an increased abundance of pre-genomic RNA under hypoxic conditions. Mapping the transcription start sites of BCP-RNAs identified a role for hypoxia to regulate pre-genomic RNA splicing that is dependent on m 6 A modification. Bioinformatic analysis of published single cell RNA-seq of murine liver showed an increased expression of the RNA demethylase ALKBH5 in the peri-central low oxygen region. In vitro studies with a human hepatocyte derived HepG2-NTCP cell line showed increased ALKBH5 gene expression under hypoxic conditions and a concomitant reduction in m 6 A-modified HBV BCP-RNA and host RNAs. Silencing the demethylase reduced the level of BCP-RNAs and host gene ( CA9, NDRG1, VEGFA, BNIP3, FUT11, GAP and P4HA1 ) transcripts and this was mediated via reduced HIFα expression. In summary, our study highlights a previously unrecognized role for ALKBH5 in orchestrating viral and cellular transcriptional responses to low oxygen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Medicine, University of Oxford, United Kingdom.
- Department of Medicine, University of California, California, United States of America.
- Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, United Kingdom.
ORCID-Profile: Jane A McKeating
Förderung
- Wellcome Trust
- NIAID NIH HHS
- Chinese Academy of Medical Sciences
- John Black Charitable Foundation
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Tsukuda, S., Harris, J. M., Magri, A., Balfe, P., Siddiqui, A., Wing, P. A. C., & McKeating, J. A. (2024). The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011917
Vancouver
Tsukuda S, Harris JM, Magri A, Balfe P, Siddiqui A, Wing PAC, et al. The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1011917
BibTeX
@article{Tsukuda2024,
author = {Tsukuda, Senko and Harris, James M and Magri, Andrea and Balfe, Peter and Siddiqui, Aleem and Wing, Peter A C and McKeating, Jane A},
title = {The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1011917}
}
EUVIMED